Cognition Therapeutics is seeking qualified vendors to bid for federal grant funded activities. Vendors with experience in neurological and neuro-ophthalmic diseases concentrating in the clinical/ non-clinical spaces should submit your information using the vendor qualification form below. Cognition Therapeutics has been awarded grants from NIH for clinical trials SHINE, SEQUEL, SHIMMER, and START. Information regarding the clinical trials can be found at www.cogrx.com/clinical-trials or www.clinicaltrials.gov. Cognition Therapeutics is an equal opportunity employer committed to diversity, equity, and inclusion. The company recognizes the importance and value brought by diversity-owned businesses and contractors and actively requests competitive bidding participation.